—
C+
C+ The full Closelook — membership. Open the C+ overview

Smith & Nephew SNATS Inc (SNN) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Smith & Nephew SNATS Inc ranks 2 of 7 in its cohort on the Closelook composite (55/100) — the cohort is led by Sectra AB (publ) at 58/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
SNN Smith & Nephew SNATS Inc 55 22 54 74 warn 24.8%
SECT-B.ST Sectra AB (publ) 58 74 64 12 bull 15.3%
SOON.SW Sonova H Ag 55 80 71 56 bull 5.2%
CEVI.ST CellaVision AB 54 64 67 32 bull 12.2%
SYK Stryker Corporation 51 23 64 45 bear 28.9%
SHL.DE Siemens Healthineers AG 47 45 46 57 neutral 20.9%
PHIA.AS Koninklijke Philips NV 45 28 43 72 bear 22.2%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Smith & Nephew SNATS Inc's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Sectra AB (publ) (SECT-B.ST), Sonova H Ag (SOON.SW), CellaVision AB (CEVI.ST), Stryker Corporation (SYK), Siemens Healthineers AG (SHL.DE), Koninklijke Philips NV (PHIA.AS).

How does SNN score against its peers?

Smith & Nephew SNATS Inc's composite reads 55/100, ranking 2 of 7 in its cohort as of 2026-09-18; the cohort's highest composite is Sectra AB (publ) at 58/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.